Efficacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma: a multicenter, single-arm, phase 2 study.

Lancet Reg Health West Pac · 2023 · PMC9985015 · PMID 36879786

Europe PMC DOI

hedged sentence

0.0770

closest p · 1.5× alpha

0.0770

boldest claim

The sentences

did not reach statistical significanceP = 0.077so close (0.05 < p ≤ 0.1)

In our study, baseline plasma EBV DNA < 1000 copies/ml was associated with better DCR, PFS and OS, although its correlation with ORR did not reach statistical significance ( P = 0.077).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.